NCT02580058 2023-07-10
JAVELIN Ovarian 200
Pfizer
Phase 3 Completed
Clinical Trials
4 trialsNCT03690739 2022-02-24
Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer
AGO Research GmbH
Phase 3 Terminated
NCT01837251 2021-07-13
Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
AGO Research GmbH
Phase 3 Completed
NCT01281254 2017-12-02
TRINOVA-2
Amgen
Phase 3 Terminated